Investigation Overview
April 7, 2017 (Shareholders Foundation) - An investigation on behalf of current long-term investors in shares of HedgePath Pharmaceuticals Inc (OTCMKTS:HPPI) was announced over potential breaches of fiduciary duties by certain officers and directors at HedgePath Pharmaceuticals Inc. The investigation by a law firm concerns whether certain HedgePath Pharmaceuticals directors breached ...
You must register (for free) or login to view the entire investigation.